The current landscape of the scientific and pharmaceutical industries presents a fascinating blend of unprecedented advancements and complex challenges that continue to redefine the sector. As these industries evolve, they encounter critical opportunities for growth alongside significant hurdles
Chinese contract research organization GemPharmatech has expanded its presence in the United States with a new facility in San Diego, announced on April 17. The facility is designed for laboratories and housing genetically engineered mouse models, aimed at enhancing their capabilities in offering
The realm of medical devices is on a transformative path, markedly influenced by the integration of advanced materials like Nitinol. Known for its remarkable superelasticity, shape memory effect, and superior damping characteristics, Nitinol stands as a cornerstone in the development of innovative
Recce Pharmaceuticals, a Sydney-based biotechnology company, has successfully raised A$15.8 million to advance its groundbreaking anti-infective drugs into Phase 3 trials. This funding was obtained through a combination of private placement and an entitlement offer. Recce's synthetic
The medical and life sciences manufacturing sector is experiencing rapid transformations, bringing forth a plethora of challenges and opportunities for industry professionals. Ascential's "2025 State of Medical & Life Sciences Manufacturing" report delves into key areas such as
The biopharmaceutical sector has witnessed significant changes in leadership roles within major Contract Development and Manufacturing Organizations (CDMOs), driving strategic growth and development. The appointment of seasoned leaders plays a crucial role in strengthening the research,